Laurus Labs Q1 Profit Soars 1144%

  Published 11 months ago

Laurus Labs posted strong Q1 FY26 growth, driven by CDMO surge, margin gains, and strategic expansion in Andhra Pradesh.

  • CDMO revenue doubled YoY to Rs 522 crore, while FDF rose 50%, supporting robust business performance.
  • EBITDA jumped 127% to Rs 389 crore; margins expanded due to operating leverage and better CDMO product mix.
  • Andhra Pradesh allotted 531.77 acres for Rs 5,630 crore Laurus Pharma Zone, expected to create 6,350 jobs.

You might like these

India Oil Demand Jumps in May

Mercedes India Q1 Sales Hit Record

RateGain & LIAT Boost Caribbean Air Connectivity

CreditAccess Grameen Jumps 5%

Adani Ports May 2025 Performance Surge

RBI Holds Repo Rate at 5.5%

Delhivery Opens Lucknow Mega Hub

News that matters the most ⚡